Literature DB >> 8902579

Fas expression and apoptosis in human B cells.

E Schattner1, S M Friedman.   

Abstract

Mechanisms of B cell apoptosis are critical in reducing aberrant B cell proliferations such as those that arise in autoimmune disease and in B cell malignancies. The physiologic interaction of CD4+ helper T cells and B lymphocytes has been extensively studied over the past two decades. Although CD4+ T cells are considered primarily to offer positive costimulatory signals for B cell differentiation into active immunoglobulin-secreting cells, recent studies have shown that CD4+ T cells are crucial in downregulating the humoral immune response. In the course of cognate interaction between CD40 ligand (CD40L)-bearing CD4+ T cells and CD40-expressing germinal center B cells, CD40 ligation results in augmented Fas expression at the B cell surface. Like CD40L, Fas ligand is expressed on activated CD4+ Th1 cells and when bound to Fas receptor on the B cell surface, initiates an apoptotic signal in that cell. Thus, CD4+ T cells limit the growth of autologous germinal center B cells by first inducing Fas expression and then instigating a death signal via Fas ligand. In this work, we will consider these observations about CD4+ T-cell-induced, Fas-mediated B cell death in the context of other factors that affect apoptosis in B cells, normal and malignant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902579     DOI: 10.1007/bf02918252

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  79 in total

1.  Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis.

Authors:  M Los; M Van de Craen; L C Penning; H Schenk; M Westendorp; P A Baeuerle; W Dröge; P H Krammer; W Fiers; K Schulze-Osthoff
Journal:  Nature       Date:  1995-05-04       Impact factor: 49.962

2.  Effect of bcl-2 on Fas antigen-mediated cell death.

Authors:  N Itoh; Y Tsujimoto; S Nagata
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

3.  Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells.

Authors:  Z Wang; J G Karras; R G Howard; T L Rothstein
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

4.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

5.  CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis.

Authors:  J Schlegel; I Peters; S Orrenius; D K Miller; N A Thornberry; T T Yamin; D W Nicholson
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

6.  Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.

Authors:  E Yang; J Zha; J Jockel; L H Boise; C B Thompson; S J Korsmeyer
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

7.  CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells.

Authors:  J C Rathmell; M P Cooke; W Y Ho; J Grein; S E Townsend; M M Davis; C C Goodnow
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

8.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

9.  A human CD4- T cell leukemia subclone with contact-dependent helper function.

Authors:  M J Yellin; J J Lee; L Chess; S Lederman
Journal:  J Immunol       Date:  1991-11-15       Impact factor: 5.422

10.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes.

Authors:  P Garrone; E M Neidhardt; E Garcia; L Galibert; C van Kooten; J Banchereau
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  8 in total

1.  Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death.

Authors:  A Dutton; J D O'Neil; A E Milner; G M Reynolds; J Starczynski; J Crocker; L S Young; P G Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

2.  Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.

Authors:  Roman Kurt Thomas; Anne Kallenborn; Claudia Wickenhauser; Joachim Ludwig Schultze; Andreas Draube; Martina Vockerodt; Daniel Re; Volker Diehl; Jürgen Wolf
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

3.  Microbial Translocation and B Cell Dysfunction in Human Immunodeficiency Virus Disease.

Authors:  Wei Jiang
Journal:  Am J Immunol       Date:  2012

4.  Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages.

Authors:  P A Kiener; P M Davis; G C Starling; C Mehlin; S J Klebanoff; J A Ledbetter; W C Liles
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307

5.  Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease.

Authors:  Xiaocong Yu; Zihai Li; Zhenxian Zhou; J Michael Kilby; Wei Jiang
Journal:  Epidemiology (Sunnyvale)       Date:  2013-02-02

6.  The Interaction of CD154 with the α5β1 Integrin Inhibits Fas-Induced T Cell Death.

Authors:  Meriem Bachsais; Nadim Naddaf; Daniel Yacoub; Suzanne Salti; Nada Alaaeddine; Fawzi Aoudjit; Ghada S Hassan; Walid Mourad
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

7.  A redox state-dictated signalling pathway deciphers the malignant cell specificity of CD40-mediated apoptosis.

Authors:  C J Dunnill; K Ibraheem; A Mohamed; J Southgate; N T Georgopoulos
Journal:  Oncogene       Date:  2016-11-21       Impact factor: 9.867

8.  Early IgE Production Is Linked with Extrafollicular B- and T-Cell Activation in Low-Dose Allergy Model.

Authors:  Dmitrii Borisovich Chudakov; Olga Dmitrievna Kotsareva; Maryia Vladimirovna Konovalova; Daria Sergeevna Tsaregorodtseva; Marina Alexandrovna Shevchenko; Anton Andreevich Sergeev; Gulnar Vaisovna Fattakhova
Journal:  Vaccines (Basel)       Date:  2022-06-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.